Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study
Autor: | Martins de Almeida, R., Mateu Arrom, L., Ortíz Núñez, A., Covernton, P.J.O., Mora Blazquez, A.M. |
---|---|
Zdroj: | In Actas Urológicas Españolas (English Edition) April 2022 46(3):184-192 |
Databáze: | ScienceDirect |
Externí odkaz: |